Advertisment
Which groups benefited most from an ECHELON-1 approach?
![](https://medicalupdateonline.com/wp-content/uploads/2018/02/Which-groups-benefited-most-from-an-ECHELON-1-approach-741x417.jpg)
Professor Stephen Ansell (Mayo Clinic, USA) discusses who might benefit most from A+AVD upfront in HL.
Interview by Esther Drain.
Advertisment
Professor Stephen Ansell (Mayo Clinic, USA) discusses who might benefit most from A+AVD upfront in HL.
Interview by Esther Drain.